RootPath's Seed VC Round

RootPath raised a round of funding on August 30, 2018.

RootPath develops a personalized T cell therapy platform that bridges precision medicine and cancer immunotherapy. It is developing technologies to precisely monitor, modulate and steer the immune sys…

Articles about RootPath's Seed VC Round: